<?xml version="1.0" encoding="UTF-8"?>
<p>A small and poorly controlled French trial reported viral clearance at day 6 in 100% of COVID‐19 patients treated with hydroxychloroquine and azithromycin, compared to 57% treated with hydroxychloroquine alone, and 13% in controls (Gautret 
 <italic>et al</italic>
 <italic>.</italic>, 
 <xref rid="mbt213592-bib-0023" ref-type="ref">2020</xref>). Other French researchers noted that no acute viral infection has been successfully treated with chloroquine in humans in the past (Touret and de Lamballerie, 
 <xref rid="mbt213592-bib-0062" ref-type="ref">2020</xref>), and even more severe viral infection was seen in chloroquine‐treated animal model for dengue fever (Guastalegname and Vallone, 
 <xref rid="mbt213592-bib-0027" ref-type="ref">2020</xref>).
</p>
